Annual report pursuant to Section 13 and 15(d)

Convertible Redeemable Preferred Stock And Stockholders' Equity - Cash proceeds, along with fair value disclosures related to grants, exercises, and vesting options (Details)

v3.24.1
Convertible Redeemable Preferred Stock And Stockholders' Equity - Cash proceeds, along with fair value disclosures related to grants, exercises, and vesting options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]      
Proceeds from stock options exercised     $ 132
Intrinsic value of stock options exercised [1]     $ 82
Weighted-average fair value of options granted per share     $ 0.66
Total fair value of shares vested during the year $ 1 $ 42 $ 404
[1] The intrinsic value of stock options exercised is the amount by which the market price of the stock on the date of exercise exceeded the exercise price of the stock on the date of grant.